AI Breakthroughs in Healthcare and Medical: 2025 News

Curious about how artificial intelligence is transforming the healthcare industry in 2025? In this article, we have explored the most recent innovations, funding announcements, and real-world applications of AI that are reshaping patient care, improving efficiency, and unlocking new frontiers in medical science. Check out these latest AI-related healthcare news and breakthroughs in 2025. 

Mediwhale Launches Retinal AI for Early Disease Detection

News Date: July 7, 2025

Mediwhale has developed an AI-powered platform that analyzes retinal images to detect heart, kidney, and eye diseases—replacing invasive diagnostics like blood tests and CT scans.

• Provides full-body health insights from simple eye scans.
• Deployed in hospitals across Dubai, Italy, and Malaysia.
• Enables early detection of silent or asymptomatic conditions.
• Reduces diagnostic delays and improves preventive care.
• Complements physician workflows with non-invasive tools.

News Resource: businessinsider.com

Isomorphic Labs’ AI-Designed Drugs Enter Human Trials

News Date: July 7, 2025

Isomorphic Labs, a DeepMind spinoff, has announced that its AI-designed drugs are set to enter human trials soon — a major milestone in AI-assisted pharmaceutical innovation.

• Uses AI to model protein interactions and design novel drugs faster than traditional methods.
• Streamlines preclinical testing and enhances the probability of clinical success.
• Reduces time-to-market by identifying effective compounds earlier in the discovery pipeline.
• Could revolutionize how we treat diseases like cancer and neurological disorders.
• Brings precision, speed, and data-driven insights to drug discovery at scale.

News Resource: hindustantimes.com

AI That Predicts Human Decisions With High Accuracy

News Date: July 6, 2025

A new AI model from EPFL (École Polytechnique Fédérale de Lausanne) mimics human decision-making with unprecedented accuracy, offering exciting applications in personalized medicine.

• Predicts individual choices by analyzing neural and behavioral patterns.
• Offers new ways to customize treatments based on patient decision profiles.
• Supports cognitive research and mental health diagnostics with AI explainability.
• Enhances doctor-patient communication by anticipating responses to care strategies.
• Opens new doors for ethical and human-centered AI in healthcare.

News Resource: scitechdaily.com

Pharma GCCs Use AI to Accelerate Drug Discovery

News Date: July 6, 2025

Pharmaceutical Global Capability Centers (GCCs) in India are leveraging AI to fast-track drug discovery and reduce R&D costs significantly.

• Employs AI models to analyze genomics, proteomics, and clinical data.
• Reduces early-stage research time by up to 50%.
• Enables high-throughput screening and molecular simulation at scale.
• Supports multinational drug pipelines with centralized AI analytics hubs.
• Encourages cross-collaboration between IT and bioscience teams.

News Resource: business-standard.com

Summit Therapeutics Partners with Akeso in $5B+ AI-Driven Immunotherapy Deal

News Date: July 6, 2025

Summit Therapeutics has entered into a landmark $5 billion+ licensing and collaboration agreement with Akeso Inc. to co-develop and commercialize the PD-1/VEGF bispecific antibody Ivonescimab, leveraging AI to enhance immunotherapy development.

• Uses AI to identify biomarker-driven responder populations for trials.
• Applies AI-powered imaging and modeling to optimize trial design and endpoints.
• Aims to accelerate development of next-gen cancer therapies.
• Targets non-small cell lung cancer and other solid tumors.
• Reinforces the growing role of AI in complex biologics and bispecifics.

News Resource: finance.yahoo.com

AI Model Accurately Detects Parkinson’s Disease

News Date: July 4, 2025

A new AI model showcased in Medscape shows high accuracy in detecting early Parkinson’s disease using brain imaging and cognitive patterns.

• Demonstrates >90% accuracy in identifying early motor and non-motor symptoms.
• Enables earlier intervention and more personalized treatment strategies.
• Could significantly improve long-term patient outcomes through timely care.
• Reduces dependency on invasive and expensive diagnostic procedures.
• Supports ongoing neurological monitoring using non-invasive data.

News Resource: medscape.com

University Hospitals Explore AI for Lung Cancer Outcomes

News Date: July 3, 2025

University Hospitals in Cleveland are studying the use of AI to improve lung cancer treatment outcomes and reduce disparities in patient care.

• Uses AI to analyze imaging, pathology, and EHR data for predictive modeling.
• Targets better detection of aggressive cancer types in underserved populations.
• Optimizes treatment plans through data fusion and pattern recognition.
• Aims to increase early diagnosis rates and survival metrics.
• Strengthens equity and precision in oncology care through AI support.

News Resource: cleveland19.com

Microsoft AI Diagnostic Orchestrator Outperforms Doctors

News Date: July 2, 2025

Microsoft has introduced the MAI-DxO platform, an LLM-powered diagnostic tool that achieves over 85% accuracy—far surpassing the average physician rate in case studies.

• Uses a “chain-of-debate” model with multiple AI agents.
• Analyzes clinical data to generate and test diagnostic hypotheses.
• Designed to support clinicians in complex decision-making.
• Sets new standards in accuracy and reasoning in medical AI.
• Still under research; not yet deployed for clinical use.

News Resource: Time.com

AI-Based Tool Enhances Kidney Transplant Prediction

News Date: July 1, 2025

According to a study in Nature Communications, an AI-based tool can now more accurately predict kidney transplant rejection risks than traditional methods.

• Analyzes thousands of immune markers to identify patterns missed by humans.
• Offers real-time, data-driven guidance on post-transplant care.
• Aims to reduce graft rejection rates and improve patient survival.
• Enhances clinicians’ ability to personalize immunosuppressive therapies.
• Marks progress in AI-powered predictive analytics for complex biological systems.

News Resource: nature.com

SandboxAQ Publishes 5.2 Million Synthetic Molecule Dataset

News Date: June 18, 2025

SandboxAQ, backed by Nvidia and spun out from Google, has released a public dataset featuring 5.2 million synthetic 3D molecular structures to accelerate AI-driven drug discovery.

• Enables AI models to better predict protein–drug binding early in development.
• Provides valuable training data far beyond naturally observed molecules.
• Aims to reduce reliance on expensive lab experiments.
• Publishes the data publicly while monetizing proprietary model innovations.
• Supports an open-science approach to AI-enhanced pharma research.

News Resource: Medpath.com

AIIMS Patna Integrates AI-Powered Devices to Enhance Patient Care

News Date: June 1, 2024

AIIMS Patna has partnered with the Ministry of Health and Family Welfare's e-health division to integrate AI-powered medical technologies aimed at advancing patient care.

• Procured advanced AI-enabled devices for diagnostics and treatment.
  
  
• AI improves diagnostic accuracy by recognizing patterns often missed by human practitioners.
  
  
• Orthopedic department introduces robotic surgeries, enhancing precision in procedures.
  
  
• Initiated AI-based tuberculosis screening across rural areas using mobile X-ray units and AI kits.
  
  
• Aims to reduce hospital crowding and improve healthcare efficiency.
  

News Resource: timesofindia.indiatimes.com

Diagnostics.ai Launches Transparent AI Platform for PCR Diagnostics

News Date: May 31, 2025

Diagnostics.ai has introduced a fully transparent machine learning platform designed for real-time PCR diagnostics, setting a new standard in AI-assisted healthcare tools. Unlike black-box models, this platform emphasizes clarity and traceability in decision-making.

• Clinicians can view how each diagnostic result is derived, boosting confidence and accountability.
  
  
• The platform is optimized for high-volume labs and supports rapid, reliable PCR testing.
  
  
• It ensures compliance with strict regulatory standards through interpretability.
  
  
• Aims to improve diagnostic accuracy while maintaining transparency in clinical environments.
  
  
• Bridges the gap between AI innovation and the trust required in medical settings.

News Resource: news-medical.net/news  

RFK Jr. Supports “AI Slop” Theory in Maha Health Report

News Date: May 30, 2024

Presidential candidate RFK Jr. has backed a controversial Maha Health report suggesting that low-quality AI-generated medical content, dubbed “AI slop,” is negatively impacting public health outcomes.

• Claims AI-generated misinformation affects decision-making and trust.
  
  
• Experts question the scientific rigor of the report.
  
  
• Highlights concerns over AI regulation in healthcare content.
  
  
• Sparks debate over quality control in AI-generated medical advice.
  
  
• Raises awareness about the risks of unchecked AI use in public health.

News Resource: theverge.com

New AI Test Helps Identify Prostate Cancer Patients Who Benefit from Abiraterone

News Date: May 30, 2025

Researchers have developed an AI-powered test that can predict which prostate cancer patients will respond well to abiraterone treatment. This advancement aims to personalize treatment plans and avoid unnecessary therapy.

• The test analyzes tumor characteristics to forecast drug efficacy.
  
  
• Helps clinicians tailor treatment, reducing exposure to ineffective medications.
  
  
• Improves patient outcomes by focusing on those who will truly benefit.
  
  
• Supports more efficient use of healthcare resources.
  
  
• A step forward in precision oncology through AI-driven decision-making.
  

News Resource: news-medical.net

AI-Powered Hearing Aids Reconnect Mainers to the Hearing World

News Date: May 30, 2025

In Maine, AI-powered hearing aids are transforming the lives of people with hearing loss by offering enhanced speech recognition and real-time sound optimization.

• Filters out background noise and focuses on speech clarity.
  
  
• Adapts to different environments for personalized sound experience.
  
  
• Users report improved communication and quality of life.
  
  
• Especially beneficial in social and public settings.
  
  
• Represents a major leap in accessible healthcare technology.
  

News Resource: newscentermaine.com

Google I/O 2025 Showcases Healthcare AI Innovations

News Date: May 30, 2025

At Google I/O 2025, Google unveiled next-gen healthcare AI tools including GenAI models for imaging interpretation, clinical documentation, and medical copilots for physicians.

• Introduced Gemini-based models for radiology and workflow automation.
• Demonstrated AI assistants that support doctors in real-time decision-making.
• Highlighted AI-powered documentation tools that integrate with EHRs.
• Showed potential to reduce burnout and improve care quality.
• Positioned Google Cloud as a leader in AI healthcare infrastructure.

News Resource: cloud.google.com

ElliQ: The AI Care Companion That Supports Aging-in-Place for Seniors

News Date: May 16, 2025

ElliQ, developed by Intuition Robotics, is an AI-powered care companion designed to help older adults live independently while staying mentally and emotionally engaged. It offers proactive wellness support and companionship.

• Initiates daily check-ins, medication reminders, and physical activity prompts.
  
  
• Uses natural language processing to engage in meaningful conversations.
  
  
• Reduces loneliness and cognitive decline among aging populations.
  
  
• Seamlessly integrates with caregivers and healthcare providers.
  
  
• Promotes healthier aging through AI-enhanced daily routines.
  

News Resource: Forbs

DSP‑0038: AI‑Designed Alzheimer’s Candidate Enters First Human Trial

News Date: May 13, 2025

Pharma researchers have fast‑tracked DSP‑0038, an AI-discovered serotonin receptor modulator for Alzheimer’s psychosis, from target identification to Phase I in just one year.

• Combines 5‑HT1A agonism with 5‑HT2A antagonism in a novel molecule.
• Highly accelerated timeline compared to typical 4–6 years.
• Demonstrates real-world impact of AI in psychiatric drug design.
• Validates AI’s role in identifying high‑value brain‑penetrant compounds.
• Marks a milestone for neurology-focused AI drug pipelines.

News Resource: europeanpharmaceuticalreview.com

ReportAid Raises €2.2M to Tackle Fragmented Healthcare Data with AI

News Date: May 6, 2025

ReportAid, a Dutch healthtech startup, has secured €2.2 million in funding to streamline European healthcare data using artificial intelligence. The platform focuses on solving the continent’s fragmented data and reporting infrastructure.

• Uses AI to generate compliant, structured medical reports from unstructured data.
  
  
• Aims to enhance efficiency and data standardization across European hospitals.
  
  
• Backed by Curie Capital and other investors.
  
  
• Supports cross-border healthcare improvements through better data flow.
  
  
• Addresses a key pain point in healthcare digitization.
  

News Resource: htworld.co.uk

Orli Secures £60,000 to Develop AI Coaching for Caregivers

News Date: March 26, 2024

Orli, a UK-based health tech startup, has raised £60,000 in pre-seed funding from Bethnal Green Ventures to develop its AI-powered coaching tool for unpaid caregivers.

• Focuses on providing emotional and practical support via AI-based conversations.
  
  
• Addresses the mental health and burnout challenges faced by caregivers.
  
  
• Early-stage funding to build MVP and conduct pilot testing.
  
  
• Supports an underserved segment in the healthcare ecosystem.
  
  
• Combines empathy, wellness, and AI for social impact.
  

News Resource: ukinvestormagazine.co.uk

Silna Health Secures $2.7M to Advance AI-Powered Women’s Health Platform

News Date: March 25, 2025

Silna Health, a startup focused on women’s health, has raised $2.7 million in funding to scale its AI-powered platform designed to improve diagnostics and care for under-researched women’s health issues.

• Offers AI-driven symptom analysis and virtual consultations.
  
  
• Targets conditions like endometriosis, PCOS, and menstrual disorders.
  
  
• Investors include Nina Capital and emerging healthtech backers.
  
  
• Promotes early detection and personalized care pathways.
  
  
• Expands access to affordable, gender-focused digital health solutions.

‍News Resource: Businesswire.com

Superpower Acquires Base to Enhance AI Doctor App with Nutrition Data

News Date: April 23, 2025

Superpower, an AI health startup, is expanding its personalized AI doctor app by acquiring Base, an at-home lab testing company specializing in diet analysis.

• Follows Superpower's $30 million Series A funding and previous acquisition of women's health startup Feminade.
  
  
• Aims to develop an AI-driven health "super app" integrating lab tests, medical records, and wearables.
  
  
• Provides personalized nutrition, sleep, and hormone optimization plans reviewed by human care teams.
  
  
• Acquisition accelerates Superpower's food-as-medicine capabilities while reducing clinical R&D costs.
  
  
• Exploring partnerships with employers to widen access to the $500 annual membership service.
  

News Resource: forbes.com.au 

Heidi Health Raises AU$16.6M to Advance AI Clinical Scribes

News Date: March 10, 2025

Heidi Health, an Australia-based healthtech startup, has secured AU $16.6 million in Series A funding to expand its AI-powered clinical-scribe technology, which automates note-taking between patients and physicians.

• Automates medical documentation during consultations in real time.
• Reduces admin workload and lets doctors focus more on patients.
• Deployed across multiple international clinics and practices.
• Supports interoperability with major electronic health records.
• Enhances clinical efficiency with accurate AI-generated summaries.

News Resource: thesaasnews.com

WHO Announces New Centre for AI in Health Governance

News Date: March 6, 2025

The World Health Organization (WHO) has launched a Collaborating Centre on AI for Health Governance to shape global standards for the safe and ethical use of AI in healthcare.

• Located at the University of Global Health Equity in Rwanda.
  
  
• Will focus on data governance, algorithm transparency, and regulatory policy.
  
  
• Aims to help countries adopt AI while minimizing risk.
  
  
• Ensures equitable AI access and protects patient rights.
  
  
• Part of WHO’s broader digital health and ethics initiative.

News Resource: who.int

London Startup Launches UK’s First Conversational AI Wearable

News Date: Feb 25, 2025

TSA member Birdie, a London-based digital health startup, has unveiled the UK’s first conversational AI wearable—a wristband that enables proactive, real-time care for older adults.

• Allows users to talk directly to an AI assistant via the device.
• Supports medication reminders, wellness checks, and emergency alerts.
• Integrates with caregiver platforms for continuous remote monitoring.
• Designed to support aging-in-place with dignity and autonomy.
• Marks a defining moment for proactive, AI-enabled elder care in the UK.

News Resource: tsa-voice.org.uk

Aidoc Receives FDA Clearance for AI-Powered Rib Fracture Triage

News Date: Feb 19, 2025

Aidoc has received FDA clearance for its latest AI algorithm that detects and prioritizes rib fractures in trauma patients, expanding its suite of radiology triage tools.

• Uses AI to analyze CT scans and flag suspected rib fractures.
• Helps trauma teams prioritize critical cases faster.
• Integrates directly into hospital radiology workflows.
• Reduces delays in diagnosing often-overlooked injuries.
• Marks the 14th FDA-cleared algorithm in Aidoc’s aiOS platform.

News Resource: mobihealthnews.com

Avandra Launches with $17.75M to Advance AI on Real-World Medical Data

News Date: Feb 18, 2025

Avandra, a new startup spun out of Evidation Health, has launched with $17.75 million in funding to harness AI for extracting insights from real-world, messy medical datasets—unlocking better drug development and patient care.

• Uses AI to analyze unstructured, incomplete, and longitudinal health data.
• Aims to modernize real-world evidence (RWE) infrastructure for life sciences.
• Helps pharma companies understand patient outcomes beyond clinical trials.
• Bridges the gap between clinical research and real-world practice.
• Backed by investors like GE Ventures and McKesson Ventures.

News Resource: businesswire.com

AI-Powered Digital Therapeutics Transform Parkinson’s Neurocare

News Date: Feb 1, 2025

A new wave of AI-powered digital therapeutics is revolutionizing neurocare for Parkinson’s disease by offering real-time symptom tracking and adaptive therapy support.

• Uses AI to tailor therapy based on patient behavior and progression.
  
  
• Enhances patient engagement and long-term care outcomes.
  
  
• Reduces caregiver burden through predictive alerts and guidance.
  
  
• Integrates with wearable devices and mobile platforms.
  
  
• Helps neurologists optimize treatment plans more efficiently.
  

News Resource: Ramaonhealthcare.com

Quibim Raises $50M to Advance AI Imaging Biomarker Technology

News Date: Jan 28, 2025

Quibim, a Spanish medical imaging company, has secured $50 million in a Series A funding round to accelerate the development of its advanced imaging biomarker technology.

• Specializes in AI-powered radiology workflows and predictive imaging models.
  
  
• Developed QP-Prostate and QP-Brain software, with regulatory clearances including CE and FDA 510(k).
  
  
• Collaborated with Microsoft to develop virtual biopsies using AI.
  
  
• Partnered with Philips to integrate AI-based imaging solutions for MR prostate exams.
  
  
• Funding aims to expand global market presence and enhance precision medicine technologies.
  

News Resource: medcitynews.com 

Tempus Unveils Olivia: AI Assistant for Precision Oncology Workflows

News Date: Nov 9, 2024

Tempus has introduced Olivia, a virtual AI assistant built to streamline clinical workflows in oncology. Olivia is designed to help healthcare providers manage complex cancer care with increased speed and intelligence.

• Supports case reviews, treatment planning, and genomic insights.
  
  
• Integrated directly into oncologists’ EMR systems and care platforms.
  
  
• Reduces administrative burden, enabling more focus on patient care.
  
  
• Leverages Tempus' vast clinical and molecular database.
  
  
• Enhances precision oncology with real-time AI-powered assistance.
  

News Resource: tempus.com

HIPAA-Compliant AI-Backed Customer Support for Healthcare: Crescendo.ai

Crescendo.ai is redefining patient communication with its fully HIPAA-compliant, AI-powered customer support platform built specifically for the healthcare industry. It ensures both efficiency and privacy while enhancing the overall patient experience.

• 🔒 HIPAA-Compliant by Design: All conversations, voice, chat, or email, are fully encrypted and compliant with healthcare data privacy regulations.
• 🩺 Healthcare-Specific Use Cases: Handles appointment scheduling, insurance queries, prescription follow-ups, and post-care instructions with precision.
• 🧠 AI with Empathy: Offers natural, human-like conversations tailored to each patient’s needs, reducing anxiety and improving satisfaction.
• 🌐 Multilingual & Omnichannel: Supports 50+ languages and works seamlessly across web, mobile, and phone for 24/7 accessibility.
• 💡 Smart Triage & Routing: Instantly prioritizes and routes complex cases to human staff, improving workflow efficiency and resolution times.
• ⚙️ EHR & CRM Integration: Easily integrates with leading healthcare systems for context-aware support and streamlined operations.

With Crescendo.ai, healthcare organizations can scale support without compromising trust, compliance, or the quality of care. Book a demo to explore more.

‍